Zenobia Taraporewala

Appearances

Plenary Session 7 - Streamlining AAV Vector-based Gene Therapy Development Through the Utilization of Manufacturing and Analytical Platform Approaches
Date
June 13, 2024
Our ability to treat diseases previously untreatable through the delivery of adeno-associated virus (AAV)-based gene therapies has been a tremendous advancement in pharmaceutical development…
Session Chairs
Diane Blumenthal
Zenobia Taraporewala
Taro Fujimori
Speakers
Andrew Harmon
Mercedes Segura Gally
Shannon Holmes
Joe Peltier